Menu
Recruiting NCT07415824

Multiple Sclerosis Implementation Network (Registry)

Observational Multiple Sclerosis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Multiple Sclerosis. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Multiple Sclerosis Implementation Network

Overview

The Multiple Sclerosis Implementation Network (MSIN) is a collaboration between the Multiple Sclerosis Association of America (MSAA), The University of Texas Health Science Center at Houston (UTHealth Houston), Dell Medical School at The University of Texas at Austin, and Novartis Pharmaceuticals Corporation. The goal of MSIN is to improve Multiple Sclerosis (MS) care, patient health, and quality of life through the development and support of implementation research and clinical practice collaboration. MSIN brings together healthcare teams, people with MS, and research leaders in MS and implementation science (IS) to learn, share, test, implement, and disseminate innovations that improve MS care, patient health, and quality of life. This ClinicalTrials.gov record pertains to the MSIN Patient Registry, which is a comprehensive database that integrates participants' electronic health records from various providers.

Primary outcome measures

  • Multiple sclerosis disability as assessed by the Patient-Determined Disease Steps (PDDS) Scale [Time frame: 5 years]
  • Perception of cognitive impairment as assessed by the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) Scale [Time frame: 5 years]

Eligibility criteria

Inclusion criteria

  • diagnosed with Multiple Sclerosis
  • can speak and understand English comfortably

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

United States · 3 centers
  • Multiple Sclerosis Association of America — Cherry Hill
  • The University of Texas at Austin — Austin
  • The University of Texas Health Science Center at Houston (UTHealth Houston) — Houston

Identifiers

NCT: NCT07415824 · HSC-SPH-24-0515 (Registry)

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗